BACKGROUND: Treatment of @entity407 is important for secondary prevention in @entity1 suffering from @entity301 . It has been proven that "young elderly" ( @entity1 aged 65-75 years) can benefit from the treatment at least as much as younger @entity1 . OBJECTIVE: To assess the adequacy of treatment as part of secondary prevention in "young elderly" and younger @entity1 . METHODS: In this prospective study, 389 @entity1 discharged from the hospital with the diagnosis of @entity301 were divided according to age groups. Data were collected regarding lipid profile examinations, dietary and drug therapy, and results of lipid profiles. RESULTS: Less than one-third of the @entity1 achieved target low density lipoprotein levels. More @entity1 in the older age group achieved the treatment goals. The goals were achieved despite the fact that the percentage of @entity1 treated with lipid-lowering drugs was lower in the older age group. CONCLUSION: The percentage of @entity1 treated for @entity407 as part of a secondary prevention plan in Israel is similar to that in other developed countries. The fact that more "young elderly" @entity1 achieve adequate lipid profiles compared to younger @entity1 indicates that there is no age discrimination towards this @entity1 group. The finding that less than one-third of the @entity1 reach the treatment goals should prompt physicians to treat @entity407 more aggressively.

Is the treatment of XXXX as secondary prevention adequate in different age groups in Israel?

@entity407 :: ('MESH:D006949', 'Disease') :: ['hyperlipidemia'] @entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity301 :: ('MESH:D003327', 'Disease') :: ['coronary heart disease']
@entity407 :: (MESH:D006949,Disease) :: ['hyperlipidemia']
